- Home
- ZLAB vs DX Comparison
ZLAB vs DX Comparison
Compare ZLAB & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | DX |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | DX |
|---|---|---|
| Price | $18.34 | $13.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $57.22 | $13.83 |
| AVG Volume (30 Days) | 937.7K | ★ 4.2M |
| Earning Date | 11-06-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 14.62% |
| EPS Growth | N/A | ★ 35.65 |
| EPS | N/A | ★ 1.66 |
| Revenue | ★ $441,629,000.00 | $230,447,000.00 |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | $134.14 |
| P/E Ratio | ★ N/A | $8.41 |
| Revenue Growth | 24.14 | ★ 87.09 |
| 52 Week Low | $16.82 | $10.79 |
| 52 Week High | $44.34 | $14.52 |
Technical Indicators
Market Signals| Indicator | ZLAB | DX |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 56.55 |
| Support Level | $17.37 | $13.81 |
| Resistance Level | $19.01 | $13.98 |
| Average True Range (ATR) | 0.63 | 0.18 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 57.51 | 69.83 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.